project id: TCGA-LGG; case submitter id: TCGA-P5-A5F6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 9.1; age at index: 26; days to birth: -9575; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1986; age at diagnosis: 9575; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 39.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9450/3; primary diagnosis: Oligodendroglioma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 35; initial weight: 140.0; sample id: f9e84d1f-da02-45f9-a26d-e95a32dcc252; sample submitter id: TCGA-P5-A5F6-01A; portion id: fc598167-3440-4f2f-a161-9b5bbb230dec; portion submitter id: TCGA-P5-A5F6-01A-11; slide id: 4f900c1c-0820-4309-85cc-393498a146b1; slide submitter id: TCGA-P5-A5F6-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; section location: TOP;